Advances in Transfusion Medicine and Immunological Research
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 624
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore recent advancements in transfusion medicine and immunological research, addressing innovations that enhance blood transfusion safety, efficacy, and patient outcomes. We welcome contributions on topics such as pre-transfusion tests, novel blood component processing and storage techniques, pathogen reduction strategies, personalized transfusion approaches, and alternatives to transfusion. The innovations imposed by new technologies and possible changes in the availability of personnel could make telemedicine and remote validation a very interesting frontier to explore, and discussion of these topics is becoming increasingly necessary. Research on transfusion-related immunology, including allo- and auto-antierythrocite antibody management, immune tolerance, and the role of the immune system in transfusion reactions, is also of interest. Additionally, studies on emerging alternatives, such as blood substitutes, cellular therapies, and immunomodulatory interventions, are encouraged. This issue seeks to provide a comprehensive platform for clinicians and researchers to share cutting-edge findings that drive the future of transfusion medicine and immunological advancements.
Dr. Luca Mele
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transfusion medicine
- immunological responses
- blood safety
- cellular therapy
- alloimmunity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
